The global Helicobacter Pylori Diagnostics Market size is anticipated to reach USD 757.84 million by 2030, according to a new report by Grand View Research. It is expected to expand at a CAGR of 4.5% over the forecast period. Increasing demand for personalized antibiotic therapy coupled with improved cost-effectiveness Helicobacter pylori (H. pylori) infection diagnosis is projected to drive the growth.
Easy accessibility and affordability of antibiotics along with short treatment durations will boost the adoption of antibiotics as well as the demand for pre and post monitoring tests. Furthermore, factors such as rising incidence of H. pylori infections, need for early diagnosis, and rapid technological advancements in diagnostic techniques will propel the market growth. However, rising pressure of maintaining economic pricing due to the extremely competitive environment may hinder the growth of the Helicobacter pylori diagnostics market.
- pylori is an aerobic gram-negative bacteria generally found in the stomach. Although advantageous for balancing the stomach ecology, it can cause infection to the inner stomach lining. The bacteria can act as one of the causative agents for stomach cancer, duodenal ulcers, gastritis and gastric ulcers, and infection to the small intestine, among other conditions. This has led to an increase in the demand for Helicobacter pylori diagnostics that enable early detection of H. pylori infection. Patients are subject to an antibiotic therapy for 10 to 14 days, in case of positive diagnosis of ulcers caused by this bacteria. Treatment for H. pylori could include a combination of antibiotics such as metronidazole, amoxicillin, clarithromycin, tetracycline, or with a proton pump inhibitor, ranitidine bismuth citrate, and bismuth subsalicylate.
The immunoassay technology segment held the largest market share in 2018 and is expected to register the fastest CAGR over the forecast period. In terms of end user, the hospital segment held the largest market share in 2018, while diagnostic laboratories is anticipated to expand at the fastest CAGR in the forthcoming years. In terms of region, North America led the global market for Helicobacter pylori diagnostics. Asia Pacific, on the other hand, is expected to witness the fastest CAGR from 2019 to 2026.
Related Press Release@ Helicobacter Pylori Diagnostics Market Report
Helicobacter Pylori Diagnostics Market Report Highlights
- Immunoassays technology held the largest market share in 2022 and is expected to witness the fastest CAGR over the forecast period
- Among end user, hospital segment held the largest market share in 2022, while the diagnostics laboratories segment is expected to demonstrate the fastest CAGR from 2023 to 2030
- Latin America is anticipated to grow at the fastest CAGR of 6.4% in the forecast period owing to the rising importance to the healthcare sector, increasing infectious diseases prevalence, and awareness.
- Key players operating in the Helicobacter pylori diagnostics market include Thermo Fisher Scientific, Biohit, Meridian Bioscience, Bio-Rad Laboratories, F. Hoffmann-La Roche, Alpha Laboratories, Quest Diagnostics, Coris BioConcept, Certest Biotec, and Epitope Diagnostics
Helicobacter Pylori Diagnostics Market Report Scope
Report Attribute
Details
Market size value in 2023
USD 555.95 million
Revenue forecast in 2030
USD 757.84 million
Growth rate
CAGR of 4.5% from 2023 to 2030
Base year for estimation
2022
Historical data
2018 - 2021
Forecast period
2023 - 2030
Request For a Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/6674/rfc
Helicobacter Pylori Diagnostics Market Segmentation
Grand View Research has segmented the global helicobacter pylori diagnostics market on the basis of technology, end user, and region:
Helicobacter Pylori Diagnostics Type Outlook (Revenue, USD Million, 2018 - 2030)
- Instruments
- Reagents
- Services
Helicobacter Pylori Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Immunoassays
- POC
- Molecular Diagnostics
Helicobacter Pylori Diagnostics End-user Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Diagnostics Laboratories
- Clinics
Helicobacter Pylori Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Sweden
- Norway
- Denmark
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Kuwait
The Helicobacter Pylori Diagnostics Market Research Report 2019 gives an extensive evaluation of the industry to help the reader gain the upper hand in the competitive landscape by employing optimal tactics and understanding the essential market elements in the Helicobacter Pylori Diagnostics This report gives a critical overview of every market segment categorized in terms of market size, share, and regional analysis of the Helicobacter Pylori Diagnostics sector.
Through the statistical analysis performed in the report, it is visible that the market will continue to grow at a steady pace in the coming years, alongside the changing market dynamics.This report covers the recent COVID-19 incidence and its impact on Helicobacter Pylori Diagnostics.
This study assesses the current landscape of the ever-evolving business sector and the present and future effects of COVID-19 on the market.To get a Free Sample PDF Brochure of the Helicobacter Pylori Diagnostics Market Research Report, Visit @ https://www.reportsanddata.com/sample-enquiry-form/3535Firstly the report gives the Holistic view of the market evaluated in terms of size, share, market value, production, and regional analysis of the Helicobacter Pylori Diagnostics sector.
Furthermore, the report provides a detailed examination of other aspects including the factors boosting the growth of the market, regulatory policies, technological innovations, good prospects, impact analysis of drivers and restraints, and other factors affecting the demand and supply dynamics of the Helicobacter Pylori Diagnostics market.
These market aspects collectively form part of the overall market analysis performed in the report to forecast estimated values for the same for the forecast period from 2019 to 2026.Leading Players included in the Helicobacter Pylori Diagnostics report are:Thermo Fisher Scientific, Biohit, Quest Diagnostics, Meridian Bioscience, Bio-Rad Laboratories, Alpha Laboratories, F. Hoffmann-La Roche, Coris BioConcept, Certest Biotec, and Epitope Diagnostics.
Helicobacter Pylori Diagnostics Market Basic Segmentation: By Technology (Revenue, USD Million, 2017 - 2027)ImmunoassaysPOCMolecular Diagnostics By End-User (Revenue, USD Million, 2017 - 2027)HospitalsDiagnostics LaboratoriesClinics Get the Discount on the Helicobacter Pylori Diagnostics Report @ https://www.reportsanddata.com/discount-enquiry-form/3535 Additionally, the report categorizes the market into different segments of the Helicobacter Pylori Diagnostics market and breaks down the details into various segments and subsequent for or better understanding.
The latest trending report Global Helicobacter Pylori Diagnostics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The Helicobacter Pylori Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.This report also researches and evaluates the impact of Covid-19 outbreak on the Helicobacter Pylori Diagnostics industry, involving potential opportunity and challenges, drivers and risks.
We present the impact assessment of Covid-19 effects on Helicobacter Pylori Diagnostics and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.
).Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/25847-helicobacter-pylori-diagnostics-market-analysis-reportThe major players covered in Helicobacter Pylori Diagnostics are:Sekisui DiagnosticsEKF DiagnosticsMeridian BioscienceF.
Hoffmann-La RocheAlpha LaboratoriesMedline IndustriesHalyard HealthThermo Fisher ScientificBio-Rad LaboratoriesQuidelCardinal HealthCoris BioConceptBeckman CoulterAgilent TechnologiesBy Type, Helicobacter Pylori Diagnostics market has been segmented into:Invasive TechniquesNon-invasive TechniquesBy Application, Helicobacter Pylori Diagnostics has been segmented into:Hospitals and ClinicsDiagnostic LaboratoriesThe report offers in-depth assessment of the growth and other aspects of the Helicobacter Pylori Diagnostics market in important countries (regions), including:North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)South America (Brazil, Argentina, Colombia)Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Helicobacter Pylori Diagnostics Market @ https://www.decisiondatabases.com/contact/download-sample-25847There are 14 Chapters to deeply display the global Helicobacter Pylori Diagnostics market.1 Helicobacter Pylori Diagnostics Market Overview2 Company Profiles3 Global Helicobacter Pylori Diagnostics Market Competition, by Players4 Global Helicobacter Pylori Diagnostics Market Size by Regions5 North America Helicobacter Pylori Diagnostics Revenue by Countries6 Europe Helicobacter Pylori Diagnostics Revenue by Countries7 Asia-Pacific Helicobacter Pylori Diagnostics Revenue by Countries8 South America Helicobacter Pylori Diagnostics Revenue by Countries9 Middle East and Africa Revenue Helicobacter Pylori Diagnostics by Countries10 Global Helicobacter Pylori Diagnostics Market Segment by Type11 Global Helicobacter Pylori Diagnostics Market Segment by Application12 Global Helicobacter Pylori Diagnostics Market Size Forecast (2021-2025)13 Research Findings and Conclusion14 AppendixPurchase the complete Global Helicobacter Pylori Diagnostics Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-25847Other Reports by DecisionDatabases.com:Global POC Diagnostics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025Global Influenza Diagnostics Market 2020 by Company, Regions, Type and Application, Forecast to 2025Global Sepsis Diagnostics Market 2020 by Company, Regions, Type and Application, Forecast to 2025About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%.
H. pylori bacteria causes ulcer.
Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-helicobacter-pylori-diagnostics-2021-2027-637 In terms of geography, the Europe accounted for the majority market shares during 2017 and this mainly accounted to the growing prevalence of peptic ulcer disease and gastritis.
The increasing patient pool looking for the early detection of symptoms and treatment is boosting the demand for helicobacter pylori diagnostics in the region.
Owing to the continuous efforts of vendors to develop a vaccination for H. pylori infection and the introduction of improved diagnostic techniques, the market will continue to witness considerable growth in this region during the next four years as well.
Additionally, they are also focusing on the development of vaccines and enhancing their presence in the regional and untapped markets.
